Begin main content

Call for Patient Input and Clinical Experts: Aimovig

Published on: April 4, 2019
Result type: News

CADTH has received the following notice(s) of pending drug submission(s).

Brand name Aimovig
Generic name erenumab
Manufacturer Novartis Pharmaceuticals Canada Inc.
Indication(s) Migraine
Project Number SR0578-000
Call for patient input 2019-04-04
Patient input deadline 2019-05-27
Submit patient input Submit
Register as Clinical Expert Register